comparemela.com
Home
Live Updates
OSE Immunotherapeutics : and Boehringer Ingelheim expand collaboration to develop first in class treatments for cancer and cardio renal metabolic diseases : comparemela.com
OSE Immunotherapeutics : and Boehringer Ingelheim expand collaboration to develop first in class treatments for cancer and cardio renal metabolic diseases
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
Nantes,...
Related Keywords
Ingelheim
,
Rheinland Pfalz
,
Germany
,
France
,
French
,
Nicolas Poirier
,
Kate Barrette
,
Florence Portejoie
,
Cliver Wood
,
Reinhard Malin
,
Melzer Cohen
,
Linkedin
,
Boehringer Ingelheim
,
International Review Of Cell
,
Veloxis Pharmaceuticals Inc
,
Corporate Affairs
,
Nantes University Hospital
,
Animal Health
,
Corporate Senior Vice President
,
Global Head
,
Discovery Research
,
Molecular Biology
,
Human Pharma
,
Cell Lung Cancer
,
Ulcerative Colitis
,
Veloxis Pharmaceuticals
,
Unit Comms
,
Universal Registration Document
,
comparemela.com © 2020. All Rights Reserved.